FIELD: medicine; pharmaceuticals.
SUBSTANCE: present invention relates to compounds and pharmaceutically acceptable salts thereof, which are used in treating neoplastic diseases or disorders, a pharmaceutical composition containing such a compound and a method of producing said compound. A drug for treating a neoplastic disease or (dys) proliferative disorder containing a compound selected from a group consisting of: 
, 
, 
, 
, 
. Drug for treating malignant tumor containing compound 
.
EFFECT: disclosed are compounds used in treating neoplastic diseases.
14 cl, 9 dwg, 2 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BRUTON'S TYROSINE KINASE INHIBITORS | 2013 |
|
RU2619465C2 |
| CDK4/6 INHIBITOR | 2017 |
|
RU2747311C2 |
| LOW-MOLECULAR CONJUGATES FOR INTRACELLULAR DELIVERY OF BIOLOGICALLY ACTIVE COMPOUNDS | 2011 |
|
RU2629957C2 |
| LOW-MOLECULAR CONJUGATES FOR INTRACELLULAR DELIVERY OF NUCLEIC ACIDS | 2011 |
|
RU2582235C2 |
| 2,2,2-TRIFLUOROETHYL-THIADIAZINES | 2015 |
|
RU2692102C2 |
| RESORCINOL DERIVATIVE AS HSP90 INHIBITOR | 2016 |
|
RU2697703C2 |
| PYRAZOLOPYRIMIDINE DERIVATIVE AND USE THEREOF | 2016 |
|
RU2735522C2 |
| COMPOSITIONS AND METHODS OF TREATING KIT- AND PDGFRα-MEDIATED DISEASES | 2020 |
|
RU2817354C2 |
| SUBSTITUTED INDOLE COMPOUNDS AS REDUCING REGULATORS OF ESTROGEN RECEPTORS | 2017 |
|
RU2722441C2 |
| PYRROLIDINE DERIVATIVES AS PPAR AGONISTS | 2017 |
|
RU2711991C1 |
